Medscape: Mild Liver Enzyme Increases Seen in COVID-19 Patients in China

UC digestive diseases expert discusses COVID-19's impact on the liver

Close to 30% of COVID-19 patients presented with mildly elevated liver enzymes in a retrospective study in China. Enzyme levels did not rise significantly during hospitalization and no patients experienced liver failure, however. Kenneth Sherman, MD, PhD, Director of the UC Division of Digestive Diseases and UC Health physician, spoke with journalist Marilynn Larkin about possible liver damage associated with SARS-CoV-2 and how pre-existing liver disease could make individuals more susceptible to infection leading to COVID-19.

Read the entire interview online.

Learn more about Sherman's COVID-19 research.

Featured image at top: Kenneth Sherman, MD, PhD, shown in the UC College of Medicine. Photo/Colleen Kelley/UC Creative + Brand.

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

1

Two College Credit Plus high school students receive bachelor’s...

May 4, 2025

Two high school students received bachelor's degrees at the University of Cincinnati's Spring Commencement. Caden Elrod, a senior at Walnut Hills High School in Cincinnati, and Sai Gollamudi, a senior at Centerville High School in Centerville, receive their degrees while also completing their diplomas. They are first high school students in UC's College Credit Plus Program to earn bachelor's degrees.

3

A farewell for the iconic Crosley Tower

May 1, 2025

The Cincinnati Business Courier reports that UC Board of Trustees approved $47.3 million for remediation and demolition of Crosley Tower. There are mixed feelings about what has been dubbed by some as the ugliest building on a U.S. college campus.

Debug Query for this